FDA Office of Regulatory Affairs Realignment to Begin in May
By Michael Mezher -
Published 28 March 2017
The US Food and Drug Administration's (FDA) Office of Regulatory Affairs (ORA), which carries out the agency's inspection program, will officially begin a major overhaul in the coming weeks, according to FDA's Center for Devices and Radiological Health (CDRH) Director Jeffrey Shuren.
Categories: News, US, FDA, Compliance, Medical Devices
Tags: Office of Regulatory Affairs, Inspections, Jeffrey Shuren, House Energy & Commerce